Knowledge of norovirus prevention and control among infection preventionists.

Am J Infect Control

Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC.

Published: June 2014

A Web-based survey was administered to infection preventionists (IPs) (N = 941) to characterize awareness and knowledge of norovirus (NoV). Only 44% of respondents correctly identified NoV as one of the 3 most common foodborne pathogens in the United States, and 5% correctly identified the 3 most common settings for NoV outbreaks. Several gaps in IPs' knowledge of NoV were identified; specifically, IPs could benefit from learning more about the natural history of NoV, modes of transmission, and cleaning and disinfection processes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712436PMC
http://dx.doi.org/10.1016/j.ajic.2014.02.004DOI Listing

Publication Analysis

Top Keywords

knowledge norovirus
8
infection preventionists
8
correctly identified
8
nov
5
norovirus prevention
4
prevention control
4
control infection
4
preventionists web-based
4
web-based survey
4
survey administered
4

Similar Publications

Viral infections in celiac disease: what should be considered for better management.

Clin Exp Med

December 2024

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Following a gluten-free diet (GFD) is known as the main effective therapy available for celiac disease (CD) patients, which in some cases is not enough to heal all patients presentations completely. Accordingly, emerging researchers have focused on finding novel therapeutic/preventive strategies for this disorder. Moreover, previous studies have shown that celiac patients, especially untreated subjects, are at increased risk of developing viral and bacterial infections, which can become a challenge for the clinician.

View Article and Find Full Text PDF

Assessing the basis for regulatory crediting of virus LRVs for secondary biological wastewater treatment: A systematic review.

Water Res

November 2024

Southern Nevada Water Authority, P.O. Box 99954, Las Vegas, NV 89193, United States. Electronic address:

Regulatory frameworks for potable reuse often include stringent log reduction value (LRV) targets to ensure public health protection against exposure to viruses and protozoa. To achieve overall LRV targets and reduce associated capital and operational costs, it is important to maximize LRV credits awarded to each unit process in a potable reuse treatment train. This may include processes that are historically uncredited or undercredited, such as secondary biological wastewater treatment incorporating activated sludge and secondary clarification.

View Article and Find Full Text PDF

Human norovirus cultivation models, immune response and vaccine landscape.

Adv Virus Res

October 2024

Department of Microbiology and Immunology, University of Melbourne, within the Peter Doherty Institute for Infection and Immunity, Parkville, Melbourne, VIC, Australia. Electronic address:

Norovirus infections are a leading cause of gastroenteritis worldwide. Despite the substantial global health burden and economic impact, there are currently no approved antiviral therapeutics or vaccines. Additionally, much of our knowledge of norovirus comes from experiments using surrogate viruses, such as murine norovirus and feline calicivirus.

View Article and Find Full Text PDF

Advances in human norovirus research: Vaccines, genotype distribution and antiviral strategies.

Virus Res

December 2024

Department of Laboratory Medicine, Department of Microbiology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212003,PR China. Electronic address:

Article Synopsis
  • Norovirus is a single-stranded RNA virus from the Caliciviridae family and is a leading cause of acute gastroenteritis, primarily transmitted through the fecal-oral route and sometimes by airborne means.
  • Symptoms of norovirus infection include nausea, vomiting, diarrhea, and stomach cramps, but there are currently no vaccines or effective antiviral treatments available.
  • The paper aims to review and synthesize recent research on norovirus to improve understanding of its transmission, immune response, and pathogenesis, guiding future studies in the field.
View Article and Find Full Text PDF

Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies.

Immunol Rev

November 2024

Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, Université Paris Cité, INSERM UMR 1163, Paris, France.

Article Synopsis
  • - Enteric viruses are a leading cause of acute gastroenteritis globally, particularly affecting children and the elderly, and can also lead to severe neurological diseases like poliomyelitis.
  • - Understanding of immune responses to these viruses is primarily derived from animal studies, although vaccines (like those for poliovirus and rotavirus) have advanced our knowledge, particularly regarding protective immunity.
  • - Research on Inborn Errors of Immunity highlights the importance of antibodies, showing that individuals with inadequate antibody production are more susceptible to prolonged enteric viral infections and related neurological issues due to the role of B cells and immunoglobulins in viral control.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!